Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Guardant Health's Total Liabilities for the quarter that ended in Jun. 2026 was $2,135 Mil.
Guardant Health's quarterly Total Liabilities
declined
from Dec. 2025 ($2,112.97 Mil) to Mar. 2026 ($2,096.36 Mil) but then
increased
from Mar. 2026 ($2,096.36 Mil) to Jun. 2026 ($2,135.16 Mil).
Guardant Health's annual Total Liabilities
declined
from Dec. 2023 ($1,627.74 Mil) to Dec. 2024 ($1,625.26 Mil) but then
increased
from Dec. 2024 ($1,625.26 Mil) to Dec. 2025 ($2,112.97 Mil).
The historical data trend for Guardant Health's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
Guardant Health's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guardant Health (GH) has a Total Liabilities of $2,135 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Guardant Health and its competitors.
Is Guardant Health's Total Liabilities too high?
Guardant Health's current Total Liabilities is $2,135 Mil. Overall, Guardant Health has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guardant Health's Total Liabilities compare to MEDP and LH?
Guardant Health's Total Liabilities of $2,135 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Diagnostics & Research company?
A good Total Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Guardant Health and its competitors. Guardant Health's current Total Liabilities is $2,135 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardant Health stock overvalued right now?
Based on GuruFocus' analysis, Guardant Health (GH) is currently considered Significantly Overvalued. The stock's GF Value™ is $65.16, compared to a current price of $159.84 — trading 145.3% above its estimated fair value. The current Total Liabilities is $2,135 Mil. Guardant Health's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Guardant Health (GH), the current Total Liabilities is $2,135 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guardant Health (GH) Overvalued in 2026?
Based on GuruFocus' analysis, Guardant Health stock appears to be overvalued.
The current stock price of $159.84 is trading 145.3% above its estimated GF Value™ of $65.16.
GuruFocus considers Guardant Health to be Significantly Overvalued.
Key valuation signals for GH:
Total Liabilities: $2,135 Mil
GF Value™: $65.16 vs. price of $159.84 (145.3% above fair value)
No single metric tells the full story. See the GH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
65GF Score
Get the complete analysis for GH
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GH has been successfully added to your 
